Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-02-06
|
ATIR101™ (Allodepleted T-cell ImmunotheRapeutics) |
blood cancer patients for whom a matched donor is not available for a standard transplantation procedure |
2 |
Kiadis Pharma (The Netherlands) |
Cancer - Oncology |
2017-02-03
|
ENT-01 (kenterin) |
constipation associated with Parkinson's Disease |
1-2 |
Enterin (USA - PA) |
Neurodegenerative diseases |
2017-02-03
|
CC100 |
amyotrophic lateral sclerosis (ALS) |
1 |
Chemigen (USA - IN) |
Neurodegenerative diseases |
2017-02-03
|
Viaskin® Milk |
milk-induced eosinophilic esophagitis |
2a |
DBV Technologies (France) |
Allergic diseases - Inflammatory diseases |
2017-02-03
|
pamrevlumab (FG-3019) |
pancreatic ductal adenocarcinoma |
1-2 |
FibroGen (USA - CA) |
Cancer - Oncology |
2017-02-03
|
AM-125 (betahistine dihydrochloride) |
Meniere's disease, vestibular vertigo |
|
Auris Medical (Switzerland) |
Otorhinolaryngology |
2017-02-02
|
TG01 |
resected pancreatic cancer |
1-2 |
Targovax (Norway) |
Cancer - Oncology |
2017-02-02
|
Makena® (hydroxyprogesterone caproate injection) subcutaneous auto-injector program (Makena SQ) |
|
3 |
Amag Pharmaceuticals (USA - MA) |
Women health |
2017-02-02
|
fitusiran (SAR439774 - ALN-AT3) |
hemophilia A, hemophilia B |
1 |
Alnylam Pharmaceuticals (USA - MA) |
Hematologic diseases - Genetic diseases - Rare diseases |
2017-02-02
|
ABX464 |
HIV infection |
1 |
Abivax (France) |
Infectious diseases |
2017-02-01
|
marzeptacog alfa |
hemophilia A |
preclinical |
Catalyst Biosciences (USA - CA) |
Rare diseases - Genetic diseases - Hematological diseases |
2017-02-01
|
Polyvac® Peanut |
peanut allergy |
preclinical |
Allergy Therapeutics (UK) |
Allergic diseases |
2017-02-01
|
UV-4B |
dengue fever |
1b |
Emergent BioSolutions (USA - MD) |
Infectious diseases |
2017-02-01
|
pembrolizumab and Lanreotide Depot |
gastroenteropancreatic neuroendocrine tumors |
1-2 |
Duke University (USA - NC) Merck&Co (USA - NJ) Ipsen (France) |
Cancer - Oncology |
2017-02-01
|
GLPG2222 |
cystic fibrosis |
2 |
Galapagos (Belgium) |
Rare diseases - Genetic diseases |
2017-01-31
|
XOMA 358 |
congenital hyperinsulinism |
2 |
Xoma (USA - CA) |
Rare diseases - Hormonal diseases - Endocrine diseases - Genetic diseases |
2017-01-31
|
XOMA 358 |
patients who experience hypoglycemia after undergoing gastric bypass surgery |
2 |
Xoma (USA - CA) |
Metabolic diseases |
2017-01-31
|
Cx611 |
severe sepsis in community-acquired pneumonia (CAP) |
1b/2a |
TiGenix (Belgium) |
Infectious diseases |
2017-01-26
|
IMGN853 - mirvetuximab soravtansine |
epithelial ovarian cancer, primary peritoneal carcinoma, Fallopian tube cancer |
3 |
immunogen (USA - MA) |
Cancer - Oncology |
2017-01-26
|
BM32 |
grass pollen allergy |
2 |
Biomay (Austria) |
Allergic diseases |